NCT03051035 - First-in-Human Study of KO-947 in Non-Hematological Malignancies | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 6, 2017

Primary Completion Date

June 2, 2020

Study Completion Date

June 2, 2020

Conditions

Advanced Malignant Neoplasm

Interventions

DRUG

KO-947

Intravenous administration

Trial Locations (5)

Memorial Sloan Kettering Cancer Center, New York

START Madrid-HM CIOCC, Madrid

Mayo Clinic, Rochester

Fox Chase Cancer Center, Philadelphia

Vall D'Hebron Institute of Oncology, Barcelona